Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
251,80 € ↑6,70 (2,73%)
2026-06-03
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionCaption Management, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Caption Management, LLC ownership in DUL / Alnylam Pharmaceuticals, Inc.

On February 14, 2025 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 0 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $0 USD as of December 31, 2024. The entity filed a previous 13F-HR on November 14, 2024 disclosing 8,405 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 10,000 of underlying shares valued at $3,308,700 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -8,405 -100.00 0 -100.00
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,405 -162,145 -95.07 2,312 -94.42 0.0369
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 170,550 56,428 49.45 41,444 143.00 0.6382
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 114,122 92,580 429.77 17,056 313.66 0.2590
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 21,542 -15,958 -42.55 4,123 -37.92 0.0556
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 37,500 37,500 6,641 0.1023
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -3,000 -100.00 0 -100.00
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,000 108 3.73 601 -12.66 0.0116
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,892 1,892 189.20 687 245.23 0.0107
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,000 -30,500 -96.83 199 -95.67 0.0027
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 31,500 31,500 4,594 0.0634
2022-02-11 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -7,800 -100.00 0 -100.00
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,800 1,200 18.18 1,473 31.75 0.0168
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,600 6,600 1,118 0.0146
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -27,000 -100.00 0 -100.00
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 27,000 27,000 3,510 0.0800
2019-01-30 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -17,500 -100.00 0 -100.00
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 17,500 17,500 1,532 0.0845
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 10,000 -33.33 3,309 -44.53 n/a n/a n/a
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 15,000 0.00 5,965 -12.81 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 15,000 50.00 6,840 109.82 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 10,000 -72.97 3,261 -67.37 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 37,000 85.00 9,991 112.28 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 20,000 4,706 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 283,000 -14.48 68,769 39.06 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 330,900 417.03 49,453 303.70 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 64,000 -43.66 12,250 -39.11 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 113,600 0.00 20,119 -6.76 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 113,600 354.40 21,577 330.85 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 25,000 0.00 5,008 -15.70 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 25,000 -50.00 5,941 -40.64 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 50,000 -87.10 10,008 -82.29 n/a n/a n/a
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 387,500 1,191.67 56,517 1,053.41 n/a n/a n/a
2022-05-13 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 30,000 -73.09 4,900 -74.08 n/a n/a n/a
2022-02-11 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 111,500 271.67 18,907 233.81 n/a n/a n/a
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 30,000 -78.89 5,664 -76.49 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 142,100 184.20 24,088 241.19 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 50,000 -78.45 7,060 -76.59 n/a n/a n/a
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 232,000 1,060.00 30,154 935.51 n/a n/a n/a
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 20,000 -91.38 2,912 -90.34 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-13 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 36,400 2,641 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 15,000 -50.00 5,965 -56.40 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 0.00 13,680 39.85 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 9,783 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 20,000 -19.68 4,706 -31.28 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 24,900 -94.91 6,848 -94.24 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 489,600 339.89 118,973 615.28 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 111,300 -15.23 16,634 -33.82 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 131,300 35.92 25,132 46.91 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 96,600 -10.56 17,108 -16.60 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 108,000 332.00 20,514 309.60 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 25,000 0.00 5,008 -15.70 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 25,000 -7.41 5,941 9.92 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 27,000 -94.90 5,405 -92.99 n/a n/a n/a
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 529,000 1,663.33 77,155 1,474.59 n/a n/a n/a
2022-05-13 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 -66.67 4,900 -67.89 n/a n/a n/a
2022-02-11 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 90,000 200.00 15,261 169.44 n/a n/a n/a
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 -82.72 5,664 -80.75 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 173,600 478.67 29,429 594.74 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 0.00 4,236 8.62 n/a n/a n/a
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 50.00 3,900 33.93 n/a n/a n/a
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 20,000 -33.33 2,912 -25.33 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-13 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 69,500 5,043 n/a n/a n/a
2019-01-30 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 2,625 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.